IMDX

Insight Molecular Diagnostics
IMDX

Overview Fund Trends Analyst Outlook Journalist POV

50 hedge funds and large institutions have $63.7M invested in Insight Molecular Diagnostics in 2019 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 12 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

0.53% more ownership

Funds ownership: 1.02% → 1.55% (+0.53%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
50
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$9.84M
2
+$5.09M
3
+$3.62M
4
SSA
Schonfeld Strategic Advisors
New York
+$3.43M
5
BC
Broadwood Capital
New York
+$2.11M

Top Sellers

1
-$17K
2
-$2.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$88K
27
$82K
28
$79K
29
$78K
30
$77K
31
$72K
32
$59K
33
$53K
34
$47K
35
$41K
36
$31K
37
$21K
38
$16K
39
$13K
40
$12K
41
$3K
42
$2K
43
$1K
44
$1K
45
$1K
46
$1K
47
$620
48
–
1
2